Erdogan-Trinkaus Ipek
Reporting owner on Forms 3, 4 and 5, CIK 2047026.
Erdogan-Trinkaus Ipek reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-12.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ETON · Eton Pharmaceuticals, Inc.CIK 1710340 | officer (Chief Commercial Officer) | 1 | 2026-11-12 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ETON · Eton Pharmaceuticals, Inc.Common Stock | 2026-11-10 | M exercised | +3,500 | $15.47 | 7,581 | Form 4 |
| ETON · Eton Pharmaceuticals, Inc.Common Stock | 2026-11-10 | S sold | -2,340 | $67.1787 | 5,241 | Form 4 |
| ETON · Eton Pharmaceuticals, Inc.Common Stock | 2026-11-10 | S sold | -1,160 | $67.8785 | 4,081 | Form 4 |
| ETON · Eton Pharmaceuticals, Inc.Employee Stock Option, derivative | 2026-11-10 | M exercised | -3,500 | $0 | 37,155 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001437749-26-036605 | Eton Pharmaceuticals, Inc. | 2026-11-12 |